四川多瑞药业
2026-01-12
Indication:
Treatment of paroxysmal nocturnal hemoglobinuria(PNH)
Treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Status: under development
Planed Batch Size:5 kg
Prev:
RetatrutideNext:
Albuvirtide